Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – In patients with chronic total coronary occlusions, drug-eluting stents (DES) have better long-term outcomes than bare metal stents, according to a paper from…
NEW YORK (Reuters Health) – Patients treated with high-dose recombinant activated factor VII (rFVIIa) for spontaneous intracerebral hemorrhage face a “small increased risk of what are usually minor…
NEW YORK (Reuters Health) – The benefits of statins are variable and depend on the agent being taken, a meta-analysis has shown. Pooled data from 10 randomized trials…
NEW YORK (Reuters Health) – A six-month course of triple antiplatelet therapy after drug-eluting stent implantation reduces the risk of revascularization for up to two years, according to…
NEW YORK (Reuters Health) – The cholesterol-lowering drug pravastatin prevents coronary heart disease in blacks, according to trial results published in the December American Heart Journal. “It’s very…
NEW YORK (Reuters Health) – In patients with atrial fibrillation, a body mass index (BMI) of 27.0 kg/meters-squared or higher increases the risk for left atrial/left atrial appendage…
NEW YORK (Reuters Health) – Interactions between clopidogrel and proton pump inhibitors (PPI) appear to have only a small effect, if any, in older patients, report researchers from…
NEW YORK (Reuters Health) – A lower than normal hematocrit level before percutaneous coronary intervention (PCI) and a drop in hematocrit after PCI are “strongly associated” with long-term…
NEW YORK (Reuters Health) – Patients with angina and multivessel coronary artery disease face poor long-term outcomes with medical management, according to a report in the December issue…
NEW YORK (Reuters Health) – Not only do high-dose statins more effectively prevent first cardiovascular events compared to moderate doses, the higher doses are also better at preventing…
